contact us krjpencn


Market Activity

현재 위치: > 뉴스현황 > Market Activity > The 18th Shanghai In...

The 18th Shanghai International Forum on Biotechnology & Pharmaceutical Industry Invitation

저자:   업로드:2016-06-06  조회수:

The 18th Shanghai International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum 2016) Seminar


    China has been described as "Generic Drugs Country", nearly 97% of Chinese pharmaceutical companies devote themselves to produce generic drugs. However, those companies are confronted with gradually increasing pressure. As it is required that higher quality and regulations of generic drugs are prescribed by CFDA to strengthen the drug safety in the market, the Chinese pharmaceutical enterprises are facing the fierce competition. It is very significant to adapt the changes and improve the level of generic research and innovation to develop generic quality conformance evaluation in the future.

    The seminar, “The Opportunities and Challenges of Generic Drugs Under New Circumstances”, is hosted by Modern Biotechnology & Pharmaceutical Office of Shanghai Municipality and co-hosted by Shanghai Center of Biomedicine Development and Shanghai Medicilon Inc. has its opening on June 21at the Shanghai International Convention Center. The purpose of this seminar is to establish a platform for exchange and cooperation between the pharmaceutical colleagues, to share the abroad working experience of conformance evaluation, to deeply interpret the newly released regulations by CFDA and to discuss t

이전:Shanghai - Boston Collaboration Promotion Party & 2016 Medicilon Client Appreciation Dinner

다음에:Join us at the CABA 2016 Annual Conference at Boston